How Has the Drug Delivery Devices Market Size Evolved in Recent Years?
The drug delivery devices market has seen considerable growth due to a variety of factors.
• In the past few years, the market size of drug delivery devices has seen a significant increase. Predictions show that it will rise from $91.03 billion in 2024 to $96.73 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.3%.
Factors contributing to this growth historically include a surge in the elderly population, an increase in the number of healthcare facilities, emerging markets' economic growth, and a hike in healthcare expenditure.
What Are The Estimated Market Size And Expected Annual Growth Rates For Globa Drug Delivery Devices Market?
The drug delivery devices market is expected to maintain its strong growth trajectory in upcoming years.
• The market for drug delivery devices is anticipated to witness substantial expansion in the coming years, with its value projected to reach $124.82 billion in 2029, highlighting a compound annual growth rate (CAGR) of 6.6%.
This surge in the forecast period can be linked to the growing number of chronic diseases, increased demand from injectables, a rising need for drug delivery devices, and the unexpected rise of acute infections. Future trends in this period include investments in microneedle drug delivery technology, the study and creation of self-injectable drug delivery devices, a focus on mergers and acquisitions, and investments in wearable drug delivery devices.
What Key Factors and Trends are Driving the Growth of the Drug Delivery Devices Market?
The escalating frequency of chronic illnesses such as cardiovascular diseases, diabetes, cancer and other ailments is anticipated to propel the drug delivery devices market. For instance, in January 2023, the National Library of Medicine, a US-based medical library managed by the federal government, predicted a 99.5% hike in the count of individuals in the United States aged 50 and older grappling with at least one chronic condition. This surge would escalate the number from 71.522 million in 2020 to 142.66 million by 2050. Different routes of drug administration exist for medical drugs. The creation of novel drug delivery methods holds significant importance in the pharmaceutical sector. Research and development (R&D) in drug delivery is on the rise globally due to the escalating frequency of these diseases. A majority of pharmaceutical firms are concentrating on diverse drug delivery technologies to yield superior merits and enhanced results for their marketed goods. Consequently, the increasing incidence of chronic diseases is leading to the augmented usage of therapeutic drugs and treatments, and this factor is likely to function as a catalyst for the growth of the drug delivery devices market.
What Are The Key Segments Within The Global Drug Delivery Devices Market?
The drug delivery devices market covered in this report is segmented –
1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery
2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings
3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications
Subsegments:
1) By Oral Drug Delivery: Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets
2) By Injectable Drug Delivery: Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps
3) By Topical Drug Delivery: Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders
4) By Ocular Drug Delivery: Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems
5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers
6) By Nasal Drug Delivery: Nasal Sprays, Nasal Powders, Nasal Drops
7) By Transmucosal Drug Delivery: Buccal Tablets, Sublingual Tablets, Mucoadhesive Films
8) By Implantable Drug Delivery: Drug-Implantable Devices, Biodegradable Implants, Reservoir-based Implants
Pre-Book The Drug Delivery Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Drug Delivery Devices Market?
Major players in the drug delivery device industry are prioritizing the creation of innovative devices such as autoinjectors integrated with complete connectivity to maintain their competitive position in the market. Autoinjectors are healthcare devices crafted for self-administration of pre-set doses of medication. For example, in May 2022, Jabil Healthcare, a firm based in the US providing healthcare manufacturing solutions, introduced the Qfinity autoinjector platform – a reusable drug delivery device. The Qfinity autoinjector platform stands unique as a straightforward, recyclable, and modular solution for self-administration of subcutaneous drugs. It provides a cost-efficient alternative to rival products and supports eco-friendly drug delivery in the pharmaceutical sector. Its flexible design is suitable for different drug quantities and consistencies, and it offers a patient-friendly form that delivers a cost that is around 65% lower per injection compared to top disposable autoinjectors. The robust Qfinity device can support over 100 injections and works with 1 mL or 2.25 mL pre-filled disposable cassettes. Furthermore, its reduced component and material usage brings about an estimated 65% cut in the cost per injection, a 60% smaller carbon footprint, a 50% reduction in manufacturing space, and a 70% decrease in capital expenditure (CAPEX).
Who Are the Key Players in the Drug Delivery Devices Market?
Major companies operating in the drug delivery devices market include:
• Becton
• Dickinson and Company
• Baxter International
• B. Braun Melsungen AG
• Catalent
• 3M Company
• West Pharmaceutical Services. Inc.
• Gerresheimer AG
• Smiths Medical
• Boehringer Ingelheim
• SMC Ltd.
• Elcam Medical
• Eli Lilly and Company
• Injex
• Novartis AG
• Novo Nordisk A/S
• Pfizer Inc
• Sanofi Sa
• Schott AG
• Terumo Corporation
• Teva Pharmaceuticals
• Ypsomed Holding AG
• F. Hoffmann-La Roche AG
• GlaxoSmithKline
• AstraZeneca
• Congenica Ltd.
• UCB
• Alkermes
• Aptalis Pharma. Inc.
• Johnson & Johnson
• Nektar Therapeutics
• SkyePharma PLC
• Pharmasyntez
• NEARMEDIC PLUS LLC
• Copernicus
• Medtronic
• Philips
• Siemens
• Stryker
• GE Healthcare
• Teleflex Medical
• Gilero
• Kedalion Therapeutics
• MediPrint Ophthalmics
• Nemera
• Pendant Biosciences
• Battelle Medical Devices
• Merck & Co. Inc.
• Antares Pharma
• Abbot
• Allergan
• Bilim Pharmaceuticals
• H&T Presspart
• Hovione Technology
• Sorrel Medical
• Syqe Medical
• Julphar
• ResMed Inc
• Covidien plc
What are the Regional Insights into the Drug Delivery Devices Market?
North America was the largest region in the drug delivery devices market in 2024. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
